A review of human carcinogens--Part A: pharmaceuticals.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 19115512)

Published in Lancet Oncol on January 01, 2009

Authors

Yann Grosse, Robert Baan, Kurt Straif, Béatrice Secretan, Fatiha El Ghissassi, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Laurent Galichet, Vincent Cogliano, WHO International Agency for Research on Cancer Monograph Working Group

Articles citing this

Preventable exposures associated with human cancers. J Natl Cancer Inst (2011) 2.14

Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Environ Health Perspect (2011) 1.51

Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation. Environ Health Perspect (2015) 1.44

Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease. Cancer Res (2009) 1.09

The carcinogenic liver fluke, Clonorchis sinensis: new assembly, reannotation and analysis of the genome and characterization of tissue transcriptomes. PLoS One (2013) 1.02

6-Thioguanine and S⁶-methylthioguanine are mutagenic in human cells. ACS Chem Biol (2010) 1.01

Unusual cancer excess after neonatal arsenic exposure from contaminated milk powder. J Natl Cancer Inst (2010) 1.00

Alcohol and hepatocellular carcinoma: a review and a point of view. World J Gastroenterol (2014) 0.98

Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study. Ophthalmology (2015) 0.89

Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2. Toxicol Sci (2011) 0.88

Crosslinking of DNA repair and replication proteins to DNA in cells treated with 6-thioguanine and UVA. Nucleic Acids Res (2011) 0.86

Beneficial bacteria inhibit cachexia. Oncotarget (2016) 0.86

Medical conditions and risk of adult myeloid leukemia. Cancer Causes Control (2012) 0.79

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report. Biol Blood Marrow Transplant (2016) 0.79

Risk factors for breast cancer, including occupational exposures. Saf Health Work (2011) 0.78

Women and heart disease: neglected directions for future research. J Cardiovasc Transl Res (2009) 0.77

Biochemical and immunological characterization of annexin B30 from Clonorchis sinensis excretory/secretory products. Parasitol Res (2014) 0.76

Impact of Cancer Therapy-Related Exposures on Late Mortality in Childhood Cancer Survivors. Chem Res Toxicol (2014) 0.76

Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea. Medicine (Baltimore) (2016) 0.76

The breast cancer epidemic: 10 facts. Linacre Q (2014) 0.76

Role of hepatic cytochrome P450 enzymes in the detoxication of aristolochic acid I; effects on DNA adduct, mutation, and tumor formation. Genes Environ (2015) 0.75

Articles by these authors

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Carcinogenicity of human papillomaviruses. Lancet Oncol (2005) 5.84

Breast-cancer screening--viewpoint of the IARC Working Group. N Engl J Med (2015) 5.48

A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol (2009) 5.15

Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol (2007) 4.60

Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. Am J Respir Crit Care Med (2010) 4.35

Effectiveness of tax and price policies in tobacco control. Tob Control (2010) 4.30

A review of human carcinogens--part D: radiation. Lancet Oncol (2009) 4.22

Carcinogenicity of alcoholic beverages. Lancet Oncol (2007) 3.98

Listing occupational carcinogens. Environ Health Perspect (2004) 3.57

Smokeless tobacco and cancer. Lancet Oncol (2008) 3.50

A review of human carcinogens--Part C: metals, arsenic, dusts, and fibres. Lancet Oncol (2009) 3.47

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncol (2005) 3.45

Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol (2011) 3.18

Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes. Lancet Oncol (2012) 3.00

The carcinogenicity of outdoor air pollution. Lancet Oncol (2013) 2.71